Singapore markets closed

Straits Times Index
3,303.19
+10.26(+0.31%)
S&P 500
5,127.79
+63.59(+1.26%)
Dow
38,675.68
+449.98(+1.18%)
Nasdaq
16,156.33
+315.33(+1.99%)
Bitcoin USD
65,234.11
+1,445.61(+2.27%)
CMC Crypto 200
1,405.18
+92.55(+7.05%)

ABT Jan 2025 55.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

56.97

0.00

(0.00%)

As of 10:54AM EDT. Market open.

Loading interactive chart…

Zacks
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?
Recently, Zacks.com users have been paying close attention to Abbott (ABT). This makes it worthwhile to examine what the stock has in store.
Zacks
PBH vs. ABT: Which Stock Is the Better Value Option?
PBH vs. ABT: Which Stock Is the Better Value Option?
PR Newswire
Abbott's Breakthrough Dissolving Stent Receives FDA Approval for Arteries Below the Knee
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System (Esprit BTK System), a breakthrough innovation for people with chronic limb-threatening ischemia (CLTI) below-the-knee (BTK). The Esprit BTK System is designed to keep arteries open and deliver a drug (Everolimus) to support vessel healing prior to completely dissolving.